These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7941872)

  • 21. Further-attenuated measles vaccine: characteristics and use.
    Krugman S
    Rev Infect Dis; 1983; 5(3):477-81. PubMed ID: 6879002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The assessment of the immunogenicity of different batches of live L-16 measles vaccine in urban and rural localities].
    Ninashvili NZ; Gelikman BG; Shavdiia NT; Elikashvili MIu; Gogokhia TsN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):72-4. PubMed ID: 8079578
    [No Abstract]   [Full Text] [Related]  

  • 23. Occurrence of antibodies against envelope components after immunization with formalin inactivated and live measles vaccine.
    Norrby E
    J Biol Stand; 1975; 3(4):375-80. PubMed ID: 1184595
    [No Abstract]   [Full Text] [Related]  

  • 24. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 25. [Persistence of immunity to attenuated measles live vaccine. V. Persistence of immunity after primary immunization with 4 strains of live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):490-2. PubMed ID: 6418341
    [No Abstract]   [Full Text] [Related]  

  • 26. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels].
    Sokhin AA; Sliusar' LI; Popov VF; Noskov FS; Radomskaia FS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):79-85. PubMed ID: 6637278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Postvaccinal antimeasles immunity in children with allergic diseases].
    Kostinov MP; Sadykova DK; Balabolkin II; Ignat'eva GV; Gervazieva VB; Gerasimova AG; Agapushkina GG
    Vopr Virusol; 1990; 35(6):512-3. PubMed ID: 2082559
    [No Abstract]   [Full Text] [Related]  

  • 28. Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6-15 months.
    Youwang Y; Ping W; Feng C
    Vaccine; 2001 Feb; 19(15-16):1998-2005. PubMed ID: 11228370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine strategies to overcome maternal antibody mediated inhibition of measles vaccine.
    Osterhaus A; van Amerongen G; van Binnendijk R
    Vaccine; 1998; 16(14-15):1479-81. PubMed ID: 9711792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
    Usonis V; Bakasenas V; Kaufhold A; Chitour K; Clemens R
    Pediatr Infect Dis J; 1999 Jan; 18(1):42-8. PubMed ID: 9951979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
    Samoĭlovich EO; Kapustik LA; Fel'dman EV; Ermolovich MA; Svirchevskaia EIu; Titov LP; Zakharenko DF; Belova EIu; Chernovetskiĭ MA; Korostik TS
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):36-40. PubMed ID: 9783398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus.
    Norrby E; Appel MJ
    Arch Virol; 1980; 66(3):169-77. PubMed ID: 7447704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 38. [Indices of humoral antimeasles postvaccinal immunity].
    Tikhonova NT; Prokudina IuA; Khrometskaia TM; Potemkina EE
    Vopr Virusol; 1975; (3):287-92. PubMed ID: 1162947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.
    van Binnendijk RS; Poelen MC; van Amerongen G; de Vries P; Osterhaus AD
    J Infect Dis; 1997 Mar; 175(3):524-32. PubMed ID: 9041322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
    Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
    J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.